172 related articles for article (PubMed ID: 19139357)
1. Uveitis treated with fluocinolone acetonide implants.
Viola F; Staurenghi G; Ratiglia R
Arch Ophthalmol; 2009 Jan; 127(1):115-6; author reply 116. PubMed ID: 19139357
[No Abstract] [Full Text] [Related]
2. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants.
Goldstein DA; Godfrey DG; Hall A; Callanan DG; Jaffe GJ; Pearson PA; Usner DW; Comstock TL
Arch Ophthalmol; 2007 Nov; 125(11):1478-85. PubMed ID: 17923537
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
[TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
Bollinger K; Kim J; Lowder CY; Kaiser PK; Smith SD
Ophthalmology; 2011 Oct; 118(10):1927-31. PubMed ID: 21652079
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME Trials.
Parrish RK; Campochiaro PA; Pearson PA; Green K; Traverso CE;
Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):426-35. PubMed ID: 27183546
[TBL] [Abstract][Full Text] [Related]
6. Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma.
Maleki A; Swan RT; Lasave AF; Ma L; Foster CS
Ophthalmology; 2016 Dec; 123(12):2630-2632. PubMed ID: 27594199
[No Abstract] [Full Text] [Related]
7. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
8. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Nazm N; Dubey S; Gandhi M; Pegu J
Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
[No Abstract] [Full Text] [Related]
9. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
10. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
11. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
[TBL] [Abstract][Full Text] [Related]
12. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
Jaffe GJ
Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
[TBL] [Abstract][Full Text] [Related]
13. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
Yang CS; Chen MJ; Chou CK; Hsu WM
Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
[TBL] [Abstract][Full Text] [Related]
14. Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma.
Ansari H; Kempen JH
Am J Ophthalmol; 2010 May; 149(5):699-700. PubMed ID: 20399922
[No Abstract] [Full Text] [Related]
15. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.
Friedman DS; Holbrook JT; Ansari H; Alexander J; Burke A; Reed SB; Katz J; Thorne JE; Lightman SL; Kempen JH;
Ophthalmology; 2013 Aug; 120(8):1571-9. PubMed ID: 23601801
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
Mruthyunjaya P; Khalatbari D; Yang P; Stinnett S; Tano R; Ashton P; Guo H; Nazzaro M; Jaffe GJ
Arch Ophthalmol; 2006 Jul; 124(7):1012-8. PubMed ID: 16832025
[TBL] [Abstract][Full Text] [Related]
17. The safety profile of long-term, high-dose intraocular corticosteroid delivery.
Holekamp NM; Thomas MA; Pearson A
Am J Ophthalmol; 2005 Mar; 139(3):421-8. PubMed ID: 15767049
[TBL] [Abstract][Full Text] [Related]
18. Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation.
Sadowsky AJ; Pecen PE; Feinstein E; Palestine AG
Ocul Immunol Inflamm; 2020 Jul; 28(5):828-832. PubMed ID: 31408390
[TBL] [Abstract][Full Text] [Related]
19. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone and IOP.
Agrawal S; Agrawal J; Agrawal TP
Ophthalmology; 2006 Jan; 113(1):159; author reply 159-60. PubMed ID: 16389110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
